Korea's AI Healthcare Innovation Faces Scaling Challenges

South Korea's AI healthcare sector has advanced from early experimental stages, evidenced by rising regulatory approvals and expanding clinical validations. However, many technologies still struggle to transition into scalable businesses, raising concerns about commercialization within the broader ecosystem.

The implications of this situation highlight the need for a strategic framework to bridge the gap between innovation and market readiness. While government support demonstrates a commitment to fostering national AI capabilities, addressing challenges in scalability could enhance South Korea's autonomy in AI healthcare and reduce reliance on foreign technologies.